IL6 and systemic lupus erythematosus: We have recently demonstrated that IL-6 [23] and IP-10 [24] are altered early in pre-clinical SLE pathogenesis, prior to the onset of clinical disease, and additional alterations occur again prior to imminent clinical disease flare in patients with classified SLE [14].